Fintel reports that on September 3, 2024, Leerink Partners initiated coverage of 10x Genomics (NasdaqGS:TXG) with a Outperform recommendation. As of August 26, 2024, the average one-year price target ...
As of June 2, 2024, the average one-year price target for 10x Genomics is 42.06. The forecasts range from a low of 26.26 to a high of $57.75. The average price target represents an increase of 89.44% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback